^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    JNJ-8902

    i
    Other names: JNJ-8902, JNJ-70218902, JNJ-902
    Associations
    News
    Trials
    Company:
    Genmab, J&J
    Drug class:
    CD3 agonist, TMEFF2 inhibitor
    Related drugs:
    Associations
    News
    Trials